10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001615774-16-006802`
Period End Date	20160630
Filing Date	20160815
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	heb-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 72 Cash Flow Statement 57 Stockholders Equity 10

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.84M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Escrow account for litigation settlement	`EscrowDeposit`	$1.75M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Escrow account for litigation settlement	`EscrowDeposit`	-	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$4.97M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$6.79M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	247.56M	shares	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	248.83M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	247.56M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$378.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$335.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	248.83M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.57M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.24M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.06M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$899.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$862.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$232.00K	USD	Point-in-time
Total assets	`Assets`	$21.92M	USD	Point-in-time
Total assets	`Assets`	$22.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.39M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.04M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	-	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$1.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.43M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 248,829,720 and 247,559,487, respectively	`CommonStockValue`	$249.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 248,829,720 and 247,559,487, respectively	`CommonStockValue`	$247.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.62M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-97.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$87.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-296.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-293.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.49M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.37M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.80M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`HealthCareOrganizationRevenue`	$47.00K	USD	1 Quarter
Clinical treatment programs	`HealthCareOrganizationRevenue`	$15.00K	USD	1 Quarter
Clinical treatment programs	`HealthCareOrganizationRevenue`	$83.00K	USD	2 Qtrs
Clinical treatment programs	`HealthCareOrganizationRevenue`	$54.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$83.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$54.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$47.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$15.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$558.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$507.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$290.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$879.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.11M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$900.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.44M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.90M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.00M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.09M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.92M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.64M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$6.55M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$2.83M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$9.91M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.95M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.49M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.90M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.82M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.81M	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest and other income/expense	`InterestAndOtherIncome`	$162.00K	USD	2 Qtrs
Interest and other income/expense	`InterestAndOtherIncome`	$116.00K	USD	2 Qtrs
Interest and other income/expense	`InterestAndOtherIncome`	$55.00K	USD	1 Quarter
Interest and other income/expense	`InterestAndOtherIncome`	$56.00K	USD	1 Quarter
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	1 Quarter
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	$-1.44M	USD	1 Quarter
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	$-1.44M	USD	2 Qtrs
Insurance proceeds from legal settlement, net	`ProceedsFromInsuranceSettlementInvestingActivities`	-	USD	2 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$-87.00K	USD	2 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	-	USD	2 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$20.00K	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.37M	USD	2 Qtrs
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.56M	USD	2 Qtrs
Gain from sale of income tax net operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.30M	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$87.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-26.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$38.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-137.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$97.00K	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.28M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.98M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.26M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.32M	USD	2 Qtrs
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	2 Qtrs
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	236.15M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	247.79M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	224.95M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	248.01M	shares	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.30M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$458.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$576.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$79.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$70.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$111.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$238.00K	USD	2 Qtrs
Realized loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-87.00K	USD	2 Qtrs
Escrow account for litigation settlement	`EscrowAccountForLitigationSettlement`	$-1.75M	USD	2 Qtrs
Escrow account for litigation settlement	`EscrowAccountForLitigationSettlement`	-	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.01M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-61.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$178.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$189.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-836.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.29M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-9.24M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$160.00K	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$240.00K	USD	2 Qtrs
Additions to patent, trademark and licensing rights	`PaymentsToAcquireIntangibleAssets`	$169.00K	USD	2 Qtrs
Additions to patent, trademark and licensing rights	`PaymentsToAcquireIntangibleAssets`	$207.00K	USD	2 Qtrs
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	-	USD	2 Qtrs
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	$2.00K	USD	2 Qtrs
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$54.00K	USD	2 Qtrs
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.92M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$1.55M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-355.00K	USD	2 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	$15.00K	USD	2 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	$1.00K	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.29M	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$163.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$162.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.28M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-577.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-314.00K	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Issuance of common stock for accounts payable	`StockIssued1`	$672.00K	USD	2 Qtrs
Issuance of common stock for accounts payable	`StockIssued1`	-	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`UnrealizedGainLossOnSecurities`	$-26.00K	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`UnrealizedGainLossOnSecurities`	$184.00K	USD	2 Qtrs
Cash paid for interest expense	`InterestPaid`	$2.00K	USD	2 Qtrs
Cash paid for interest expense	`InterestPaid`	-	USD	2 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	-	USD	2 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	$3.54M	USD	2 Qtrs

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$17.49M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$20.37M	USD	Point-in-time
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$238.00K	USD	2 Qtrs
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$163.00K	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.28M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.98M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.26M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.32M	USD	2 Qtrs
Balance, at end	`StockholdersEquity`	$17.49M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$20.37M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.